Revenue
5.62 million USD
2026 Q3 · USD
Exact inputs and evidence
- Revenue: 5615156 USD Source
Annual consolidated revenue for 2025: about USD 22.98M, using the latest reported figures. The previous period, 2024, was about USD 24.5M.
5.62 million USD
2026 Q3 · USD
-1.25%
2026 Q3 · %
1.34 million USD
2026 Q3 · USD
12.9 thousand USD
2026 Q3 · USD
2855 USD
2361437 USD
4225050 xbrli-shares
1.59% · 66.3 thousand xbrli-shares
Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-10-13.
Financial data available through: 2025-11-30.
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Prior period
USD 24.5 million
–
Current period
USD 22.98 million
–
22975408 − 24499371 = -1523963 USD
24499371 USD · 2023-12-01 – 2024-11-30
Inspect prior input Prior source22975408 USD · 2024-12-01 – 2025-11-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 307,375
–
Current period
USD 1.03 million
–
1034899 − 307375 = 727524 USD
307375 USD · 2023-12-01 – 2024-11-30
Inspect prior input Prior source1034899 USD · 2024-12-01 – 2025-11-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 2.63 million
–
Current period
−USD 904,143
–
-904143 − 2626700 = -3530843 USD
2626700 USD · 2023-12-01 – 2024-11-30
Inspect prior input Prior source-904143 USD · 2024-12-01 – 2025-11-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
Prior period
USD 724,679
–
Current period
USD 627,615
–
627615 − 724679 = -97064 USD
724679 USD · 2023-12-01 – 2024-11-30
Inspect prior input Prior source627615 USD · 2024-12-01 – 2025-11-30
Inspect current input Current sourceThe citation records this snapshot. The page link may show a newer release later.
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2020 2019-12-01 – 2020-11-30 | 22409123 | 26318757 Derived | -3909634 | -1806148 Derived | -2103486 | -1549728 Derived | Source
|
| 2021 2020-12-01 – 2021-11-30 | 24965086 | 24441678 Derived | 523408 | 310777 Derived | 212631 | -1606138 Derived | Source
|
| 2022 2021-12-01 – 2022-11-30 | 25646152 | 25041434 Derived | 604718 | 506921 Derived | 97797 | -717760 Derived | Source
|
| 2023 2022-12-01 – 2023-11-30 | 30280957 | 28749716 Derived | 1531241 | 1264272 Derived | 266969 | -896978 Derived | Source
|
| 2024 2023-12-01 – 2024-11-30 | 24499371 | 24038674 Derived | 460697 | 153322 Derived | 307375 | 1902021 Derived | Source
|
| 2025 2024-12-01 – 2025-11-30 | 22975408 | 22685953 Derived | 289455 | -745444 Derived | 1034899 | -1531758 Derived | Source
|
Amounts are exact, in USD.
Sales over time and how quickly they are changing.
Revenue reported for each complete financial period.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Revenue | 22409123 |
|
| 2021 | Revenue | 24965086 |
|
| 2022 | Revenue | 25646152 |
|
| 2023 | Revenue | 30280957 |
|
| 2024 | Revenue | 24499371 |
|
| 2025 | Revenue | 22975408 |
|
Change in revenue from the same financial period one year earlier.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | 11.4% |
|
| 2022 | Year over year | 2.7% |
|
| 2023 | Year over year | 18.1% |
|
| 2024 | Year over year | -19.1% |
|
| 2025 | Year over year | -6.2% |
|
How much revenue becomes profit, and how much cash operations generate.
Operating income, net income and free cash flow as a share of revenue.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Operating margin | -17.4% |
|
| 2021 | Operating margin | 2.1% |
|
| 2022 | Operating margin | 2.4% |
|
| 2023 | Operating margin | 5.1% |
|
| 2024 | Operating margin | 1.9% |
|
| 2025 | Operating margin | 1.3% |
|
| 2020 | Net margin | -9.4% |
|
| 2021 | Net margin | 0.9% |
|
| 2022 | Net margin | 0.4% |
|
| 2023 | Net margin | 0.9% |
|
| 2024 | Net margin | 1.3% |
|
| 2025 | Net margin | 4.5% |
|
| 2020 | Free cash flow margin | -6.9% |
|
| 2021 | Free cash flow margin | -6.4% |
|
| 2022 | Free cash flow margin | -2.8% |
|
| 2023 | Free cash flow margin | -3% |
|
| 2024 | Free cash flow margin | 7.8% |
|
| 2025 | Free cash flow margin | -6.7% |
|
Cash generated by the company’s normal business operations.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Operating cash flow | -856314 |
|
| 2021 | Operating cash flow | -985854 |
|
| 2022 | Operating cash flow | 951721 |
|
| 2023 | Operating cash flow | -55194 |
|
| 2024 | Operating cash flow | 2626700 |
|
| 2025 | Operating cash flow | -904143 |
|
Operating cash flow minus capital expenditure for the same period and unit.
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2020 | Free cash flow | -1549728 |
|
| 2021 | Free cash flow | -1606138 |
|
| 2022 | Free cash flow | -717760 |
|
| 2023 | Free cash flow | -896978 |
|
| 2024 | Free cash flow | 1902021 |
|
| 2025 | Free cash flow | -1531758 |
|
Liabilities and short-term ability to meet obligations at each period end.
Total liabilities as a share of total assets.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Liabilities / assets | 47.3% |
|
| 2021 | Liabilities / assets | 50.3% |
|
| 2022 | Liabilities / assets | 53.4% |
|
| 2023 | Liabilities / assets | 52.3% |
|
| 2024 | Liabilities / assets | 43.1% |
|
| 2025 | Liabilities / assets | 40.8% |
|
Current assets divided by current liabilities.
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2020 | Current assets / current liabilities | 1.67× |
|
| 2021 | Current assets / current liabilities | 1.58× |
|
| 2022 | Current assets / current liabilities | 1.53× |
|
| 2023 | Current assets / current liabilities | 1.61× |
|
| 2024 | Current assets / current liabilities | 1.98× |
|
| 2025 | Current assets / current liabilities | 2.3× |
|
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2020 2019-12-01 – 2020-11-30 | −USD 2.1 million Exact valueExact value: -2103486 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 856,314 Exact valueExact value: -856314 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 693,414 Exact valueExact value: 693414 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.55 million Calculation and evidence-856314 − 693414 USD Exact free cash flow: -1549728 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2020-12-01 – 2021-11-30 | USD 212,631 Exact valueExact value: 212631 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 985,854 Exact valueExact value: -985854 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 620,284 Exact valueExact value: 620284 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.61 million Calculation and evidence-985854 − 620284 USD Exact free cash flow: -1606138 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2021-03-01 – 2022-02-28 | −USD 406,489 Exact valueExact value: -406489 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2022 2021-12-01 – 2022-11-30 | USD 97,797 Exact valueExact value: 97797 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 951,721 Exact valueExact value: 951721 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.67 million Exact valueExact value: 1669481 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 717,760 Calculation and evidence951721 − 1669481 USD Exact free cash flow: -717760 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2022-03-01 – 2023-02-28 | USD 342,210 Exact valueExact value: 342210 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period. |
| 2023 2022-12-01 – 2023-11-30 | USD 266,969 Exact valueExact value: 266969 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 55,194 Exact valueExact value: -55194 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 841,784 Exact valueExact value: 841784 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 896,978 Calculation and evidence-55194 − 841784 USD Exact free cash flow: -896978 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2024 2023-12-01 – 2024-11-30 | USD 307,375 Exact valueExact value: 307375 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 2.63 million Exact valueExact value: 2626700 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 724,679 Exact valueExact value: 724679 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 1.9 million Calculation and evidence2626700 − 724679 USD Exact free cash flow: 1902021 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2025 2024-12-01 – 2025-11-30 | USD 1.03 million Exact valueExact value: 1034899 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 904,143 Exact valueExact value: -904143 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 627,615 Exact valueExact value: 627615 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.53 million Calculation and evidence-904143 − 627615 USD Exact free cash flow: -1531758 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
169 filings · 7,781 latest values · 7,781 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000007623, 7623, ARTW, artw, edgar:7623
Also known as ARTS WAY MANUFACTURING CO INC, ART’S-WAY MANUFACTURING CO., INC.